OnKure aims for $60M in new funding round – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
OnKure Therapeutics Appoints Robbie Alton, Pharm., as Vice President of Clinical Operations - read this article along with other careers information, tips and advice on BioSpace
The latest round dwarfs OnKure’s prior Series A-1 investment, which amounted to
As part of their firm’s investments, Acorn Bioventures partner Issac Manke and Cormorant Asset Management managing director Andrew Phillips will join OnKure’s board. That brings the company’s board size from four to six.
“I am grateful for the financial and strategic support from our new investors that will allow OnKure to accelerate the discovery and development of a robust pipeline focused on epigenetic regulation, delaying resistance and synthetic lethality,” OnKure CEO Tony Piscopio said in a statement.
Piscopio was previously a co-founder with Array BioPharma Inc., a Boulder oncology company that was acquired in 2019 by pharmaceutical giant Pfizer Inc. (NYSE: PFE) for
Funding Friday: Vet diagnostics, cancer treatments and chat apps raise combined $268M – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.